Cefuroxime Axetil (Ceftin(R)) A Brief Review
1997

Cefuroxime Axetil: A Brief Review

Sample size: 912 publication Evidence: moderate

Author Information

Author(s): Rachel Deanne Leder, Deborah Stier Carson

Conclusion

Cefuroxime axetil is a broad-spectrum antibiotic that is generally safe but is considered a second-line treatment due to its high cost and the availability of better alternatives.

Supporting Evidence

  • Cefuroxime axetil has a low incidence of adverse effects, primarily gastrointestinal.
  • Clinical trials showed cure rates of 96-100% for gonococcal infections with cefuroxime axetil.
  • Cefuroxime axetil is considered safe to use in pregnancy.
  • It is not the preferred antibiotic for initial treatment of infections due to better alternatives.

Takeaway

Cefuroxime axetil is a medicine that helps fight infections, but it's not the best choice because there are cheaper and just as effective options available.

Methodology

The review summarizes the pharmacokinetics, mechanism of action, clinical applications, and side effects of cefuroxime axetil based on various clinical trials.

Limitations

Cefuroxime axetil is not the drug of choice for any infection, particularly in obstetrics and gynecology, due to its high cost and better alternatives.

Participant Demographics

The study included a large cohort of patients (n=912) in clinical trials.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication